Optimizing benefits of intensive SBP control in type 2 diabetes: the crucial role of angiotensin-converting enzyme inhibitors/angiotensin-II type 2 receptor blockers
In patients with hypertension and T2DM, ACEI/ARB is the mandatory antihypertensive medication if intensive SBP control implemented for better clinical benefits.
Authors
- Xuewen Chen (ORCID: https://orcid.org/0000-0002-0392-3551)
- Ruiting Lin
- Zhe-Lin Chen (ORCID: https://orcid.org/0009-0004-8110-4844)
- Lei-Gang Tian
- Zhen-Jie Gu
- Yong‐cong Yang (ORCID: https://orcid.org/0000-0002-9991-1693)
- Lingyu Zhang (ORCID: https://orcid.org/0000-0002-4501-8445)
- Jing‐Wei Gao (ORCID: https://orcid.org/0000-0001-7917-2806)
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen Memorial Hospital (CN)
Publication Details
- Journal
- Journal of Hypertension
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1097/hjh.0000000000004037
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00